Depreciation of BIOGEN INC. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BIOGEN INC. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • BIOGEN INC. Depreciation for the quarter ending 31 Dec 2025 was $68,000,000, a 6.6% decline year-over-year.
  • BIOGEN INC. Depreciation for the twelve months ending 31 Dec 2025 was $272,800,000, a 4.8% decline year-over-year.
  • BIOGEN INC. annual Depreciation for 2025 was $272,800,000, a 4.8% decline from 2024.
  • BIOGEN INC. annual Depreciation for 2024 was $286,700,000, a 13% increase from 2023.
  • BIOGEN INC. annual Depreciation for 2023 was $254,200,000, a 6.7% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

BIOGEN INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $272,800,000 $68,000,000 -$4,800,000 -6.6% 01 Oct 2025 31 Dec 2025 10-K 06 Feb 2026 2025 FY
Q3 2025 $277,600,000 $66,500,000 -$6,200,000 -8.5% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $283,800,000 $66,900,000 -$5,000,000 -7% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $288,800,000 $71,400,000 +$2,100,000 +3% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $286,700,000 $72,800,000 +$9,300,000 +15% 01 Oct 2024 31 Dec 2024 10-K 06 Feb 2026 2025 FY
Q3 2024 $277,400,000 $72,700,000 +$8,600,000 +13% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 $268,800,000 $71,900,000 +$7,400,000 +11% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025 2025 Q2
Q1 2024 $261,400,000 $69,300,000 +$7,200,000 +12% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $254,200,000 $63,500,000 -$1,200,000 -1.9% 01 Oct 2023 31 Dec 2023 10-K 06 Feb 2026 2025 FY
Q3 2023 $255,400,000 $64,100,000 -$100,000 -0.16% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024 2024 Q3
Q2 2023 $255,500,000 $64,500,000 -$2,700,000 -4% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 $258,200,000 $62,100,000 -$14,200,000 -19% 01 Jan 2023 31 Mar 2023 10-Q 24 Apr 2024 2024 Q1
Q4 2022 $272,400,000 $64,700,000 -$2,000,000 -3% 01 Oct 2022 31 Dec 2022 10-K 12 Feb 2025 2024 FY
Q3 2022 $274,400,000 $64,200,000 -$900,000 -1.4% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $275,300,000 $67,200,000 +$12,500,000 +23% 01 Apr 2022 30 Jun 2022 10-Q 25 Jul 2023 2023 Q2
Q1 2022 $262,800,000 $76,300,000 +$27,500,000 +56% 01 Jan 2022 31 Mar 2022 10-Q 25 Apr 2023 2023 Q1
Q4 2021 $235,300,000 $66,700,000 +$16,000,000 +32% 01 Oct 2021 31 Dec 2021 10-K 14 Feb 2024 2023 FY
Q3 2021 $219,300,000 $65,100,000 +$13,600,000 +26% 01 Jul 2021 30 Sep 2021 10-Q 25 Oct 2022 2022 Q3
Q2 2021 $205,700,000 $54,700,000 +$3,400,000 +6.6% 01 Apr 2021 30 Jun 2021 10-Q 20 Jul 2022 2022 Q1
Q1 2021 $202,300,000 $48,800,000 +$400,000 +0.83% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q4 2020 $201,900,000 $50,700,000 +$5,500,000 +12% 01 Oct 2020 31 Dec 2020 10-K 15 Feb 2023 2022 FY
Q3 2020 $196,400,000 $51,500,000 +$6,000,000 +13% 01 Jul 2020 30 Sep 2020 10-Q 20 Oct 2021 2021 Q3
Q2 2020 $190,400,000 $51,300,000 +$4,300,000 +9.1% 01 Apr 2020 30 Jun 2020 10-Q 22 Jul 2021 2021 Q2
Q1 2020 $186,100,000 $48,400,000 -$4,500,000 -8.5% 01 Jan 2020 31 Mar 2020 10-Q 22 Apr 2021 2021 Q1
Q4 2019 $190,600,000 $45,200,000 -$30,200,000 -40% 01 Oct 2019 31 Dec 2019 10-K 03 Feb 2022 2021 FY
Q3 2019 $220,800,000 $45,500,000 -$19,300,000 -30% 01 Jul 2019 30 Sep 2019 10-Q 21 Oct 2020 2020 Q3
Q2 2019 $240,100,000 $47,000,000 -$17,200,000 -27% 01 Apr 2019 30 Jun 2019 10-Q 22 Jul 2020 2020 Q2
Q1 2019 $257,300,000 $52,900,000 -$12,100,000 -19% 01 Jan 2019 31 Mar 2019 10-Q 23 Apr 2020 2020 Q1
Q4 2018 $269,400,000 $75,400,000 01 Oct 2018 31 Dec 2018 10-K 03 Feb 2021 2020 FY
Q3 2018 $64,800,000 01 Jul 2018 30 Sep 2018 10-Q 22 Oct 2019 2019 Q3
Q2 2018 $64,200,000 01 Apr 2018 30 Jun 2018 10-Q 24 Jul 2019 2019 Q2
Q1 2018 $65,000,000 01 Jan 2018 31 Mar 2018 10-Q 24 Apr 2019 2019 Q1

BIOGEN INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $272,800,000 -$13,900,000 -4.8% 01 Jan 2025 31 Dec 2025 10-K 06 Feb 2026 2025 FY
2024 $286,700,000 +$32,500,000 +13% 01 Jan 2024 31 Dec 2024 10-K 06 Feb 2026 2025 FY
2023 $254,200,000 -$18,200,000 -6.7% 01 Jan 2023 31 Dec 2023 10-K 06 Feb 2026 2025 FY
2022 $272,400,000 +$37,100,000 +16% 01 Jan 2022 31 Dec 2022 10-K 12 Feb 2025 2024 FY
2021 $235,300,000 +$33,400,000 +17% 01 Jan 2021 31 Dec 2021 10-K 14 Feb 2024 2023 FY
2020 $201,900,000 +$11,300,000 +5.9% 01 Jan 2020 31 Dec 2020 10-K 15 Feb 2023 2022 FY
2019 $190,600,000 -$78,800,000 -29% 01 Jan 2019 31 Dec 2019 10-K 03 Feb 2022 2021 FY
2018 $269,400,000 +$3,100,000 +1.2% 01 Jan 2018 31 Dec 2018 10-K 03 Feb 2021 2020 FY
2017 $266,300,000 -$43,000,000 -14% 01 Jan 2017 31 Dec 2017 10-K 06 Feb 2020 2019 FY
2016 $309,300,000 +$91,400,000 +42% 01 Jan 2016 31 Dec 2016 10-K 06 Feb 2019 2018 FY
2015 $217,900,000 +$19,500,000 +9.8% 01 Jan 2015 31 Dec 2015 10-K 01 Feb 2018 2017 FY
2014 $198,400,000 +$10,600,000 +5.6% 01 Jan 2014 31 Dec 2014 10-K 02 Feb 2017 2016 FY
2013 $187,800,000 +$23,500,000 +14% 01 Jan 2013 31 Dec 2013 10-K 03 Feb 2016 2015 FY
2012 $164,300,000 +$20,400,000 +14% 01 Jan 2012 31 Dec 2012 10-K 04 Feb 2015 2014 FY
2011 $143,900,000 01 Jan 2011 31 Dec 2011 10-K 06 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.